24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cukierman
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:49
Iran war forces UAE to rethink one of the world’s biggest AI data center projects
17:08
When AI meets reality, the real revolution begins
17:03
AI is making decades of security advice harder to ignore and easier to apply
11:27
Alice: “The vulnerabilities we identify could affect billions if discovered by the wrong people”
More stories
Buzz
Most popular
Daily
Weekly
1
She sold her startup to Salesforce. Then she had four kids and started another one.
2
Meta loses its $1.5 billion AI recruit less than a year after hiring him
3
Secretive defense startup Covenant emerges from stealth with $250 million at over $1 billion valuation
4
Palo Alto Networks founder Nir Zuk raises $245 million for new cybersecurity startup
5
“We proved there are no sacred cows in technology”: Island founder says the company can be worth tens of billions
More news
Cukierman
3 stories about Cukierman
Prepare for a year of M&As in Israeli life sciences companies
28.11.21
|
Laurent Choppe
Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next
Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert
17.07.20
|
Allon Sinai
"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences
U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist
31.10.19
|
Lilach Baumer
Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics